Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,916,619
in 9 filings, $5.9M under 10b5-1 plans

Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-09-20 Boulding Mark Elliott EXEC. VP AND CLO Exercise or conversion · Stock Option (Right to Buy) −876 $30.86 $27K 69,124
2022-09-20 Boulding Mark Elliott EXEC. VP AND CLO Exercise or conversion · Stock Option (Right to Buy) −300 $30.86 $9K 68,824
2022-08-09 Okey Stephanie Director Sale −2,296 $51.62 $119K 1,867
2022-06-09 Young Alethia Director Grant or award +3,200 3,200
2022-06-09 Young Alethia Director Grant or award +1,867 5,067
2022-06-09 Young Alethia Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2022-06-09 Young Alethia Director Grant or award · Stock Option (Right to Buy) +7,000 7,000
2022-06-09 Svoronos Dawn Director Sale −738 $27.20 $20K 29,017
2022-06-07 Peltz Stuart Walter CHIEF EXECUTIVE OFFICER Sale −407 $26.83 $11K 38,239
2022-04-19 Klein Matthew B. CHIEF OPERATING OFFICER Sale −897 $42.52 $38K 56,564
2022-04-19 Pauwels Eric CHIEF BUSINESS OFFICER Sale −822 $42.52 $35K 49,772
2022-04-14 Peltz Stuart Walter CHIEF EXECUTIVE OFFICER Sale −82 $45.28 $4K 38,646
2022-04-13 Boulding Mark Elliott EXEC. VP AND CLO Exercise or conversion +2,276 $11.23 $26K 63,386
2022-04-13 Boulding Mark Elliott EXEC. VP AND CLO Sale −2,276 $45.17 $103K 61,110
2022-04-13 Boulding Mark Elliott EXEC. VP AND CLO Exercise or conversion · Stock Option (Right to Buy) −2,276 $11.23 $26K 0
2022-04-05 Boulding Mark Elliott EXEC. VP AND CLO Exercise or conversion +5 $11.23 $56 61,115
2022-04-05 Boulding Mark Elliott EXEC. VP AND CLO Sale −5 $45.00 $225 61,110
2022-04-05 Boulding Mark Elliott EXEC. VP AND CLO Exercise or conversion · Stock Option (Right to Buy) −5 $11.23 $56 2,276
2022-03-31 Hill Emily Luisa CHIEF FINANCIAL OFFICER Sale −7,910 $37.78 $299K 29,259
2022-02-10 Boulding Mark Elliott Exec. VP and CLO Exercise or conversion +2,282 $11.23 $26K 63,392

Page 46 of 53 · 1,049 trades